CHAPEL HILL, N.C., July 10 /PRNewswire/ -- "The DMs will be the key to evolving the future sales model," a sales leader said in Best Practices, LLC's latest report. The research establishes that the District Sales Manager (DM) is the cornerstone of pharmaceutical sales force effectiveness. Continued field force success depends largely on the ability of companies to evolve their DM positions to meet the needs of the complex, fast-changing bio-pharma industry.
Best Practices, LLC initiated this research to help executives who oversee or train bio-pharmaceutical field sales staff to understand how industry pressures are accelerating sales force evolution and impacting district manager effectiveness. Executives can use the forward-looking benchmarks in this report to plan and implement changes needed to help DMs sustain high performance levels.
Report excerpt, "The High Performing Pharmaceutical District Sales Manager: Current Trends & Future Directions," is available at http://www3.best-in-class.com/rr965.htm
Sample key findings that emerged from this research are the following:
-- The DM Role Is Expected to Become a More Strategic Position -- Time & Resources Are Shifting from Tactical to Strategic Activities
-- Regional Managers Are a Source of Untapped Productivity -- Regional Managers Are the First Source of Change
The cross-industry report covers 26 leading bio-pharma companies and interviewed forty-six managers and executives. Participants included Amgen, Eli Lilly, Roche, Sanofi-Aventis, Merck, Abbott and Wyeth.
For more information, on Best Practices, LLC's research and services, contact Cameron Tew, Manager of Research and Publishing at Best Practices, LLC at (919) 767-9246 or email@example.com.
ABOUT BEST PRACTICES, LLC
Best Practices, LLC, conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. Best Practices, LLC has been a leader in pharmaceutical research and consulting for nearly 15 years; our clients include 43 out of the top 50 pharmaceutical companies.
|SOURCE Best Practices, LLC|
Copyright©2008 PR Newswire.
All rights reserved